회사소개
CEO인사말
기업이념
회사연혁
조직도
오시는길
바이오메디컬
토탈헬스케어
원스톱서비스
파트너쉽
커뮤니티
공지사항
질문답변
스케쥴
채용공고
서비스상담
커뮤니티
COUMUNITY
공지사항
질문답변
스케쥴
채용공고
(주)파마존
password
<table cellspacing="0" cellpadding="0" width="652" border="0" style="border-spacing: 0px; border-collapse: collapse; margin: 0px; padding: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; color: rgb(0, 0, 0); font-size: 12px; outline-width: 0px; outline-style: none;"><tbody style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><table cellspacing="0" cellpadding="0" width="652" border="0" style="border-spacing: 0px; border-collapse: collapse; background-color: transparent; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tbody style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td colspan="2" style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><div class="detailL" style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;">올해 마지막 대형병원에 입성한 약제들 살펴 보니…</div></td></tr><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td colspan="2" style="box-sizing: border-box; padding: 10px 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><a class="top_middle_title1" style="box-sizing: border-box; background-color: transparent; color: rgb(0, 0, 0); text-decoration-line: underline; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-style: none; outline-width: 0px; outline-color: initial !important;">서울대·서울아산·세브란스병원 12월 DC 결과 분석</a></td></tr><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td width="580" align="left" style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><table cellspacing="0" cellpadding="0" width="580" border="0" style="border-spacing: 0px; border-collapse: collapse; background-color: transparent; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tbody style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td width="200" align="left" style="box-sizing: border-box; padding: 10px 0px 5px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><a class="plan_1_1" style="box-sizing: border-box; background-color: transparent; color: rgb(0, 0, 0); text-decoration-line: underline; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-style: none; outline-width: 0px; outline-color: initial !important;">이효정기자 hyo87@medipana.com</a></td><td width="380" align="left" style="box-sizing: border-box; padding: 10px 0px 5px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><a class="plan_1_1" style="box-sizing: border-box; background-color: transparent; color: rgb(0, 0, 0); text-decoration-line: underline; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-style: none; outline-width: 0px; outline-color: initial !important;">2015-12-31 06:09</a></td></tr></tbody></table></td><td style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><table cellspacing="0" cellpadding="0" width="72" border="0" style="border-spacing: 0px; border-collapse: collapse; background-color: transparent; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tbody style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><a style="box-sizing: border-box; background-color: transparent; color: rgb(0, 0, 0); text-decoration-line: underline; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-style: none; outline-width: 0px; outline-color: initial !important;"></a></td><td style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><a href="http://medipana.com/news/news_list.asp?Page=&sWord=&MainKind=A&NewsKind=5&vCount=12&vKind=1" style="box-sizing: border-box; background-color: transparent; color: rgb(0, 0, 0); margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-style: none; outline-width: 0px; outline-color: initial !important;"></a> </td><td style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><a style="box-sizing: border-box; background-color: transparent; color: rgb(0, 0, 0); text-decoration-line: underline; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-style: none; outline-width: 0px; outline-color: initial !important;"></a></td></tr></tbody></table></td></tr><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td bgcolor="#afafaf" height="2" colspan="2" style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"></td></tr><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td height="10" colspan="2" style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"></td></tr><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td align="left" style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><table cellspacing="0" cellpadding="0" width="210" border="0" style="border-spacing: 0px; border-collapse: collapse; background-color: transparent; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tbody style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td width="63" style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><a style="box-sizing: border-box; background-color: transparent; color: rgb(0, 0, 0); text-decoration-line: underline; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-style: none; outline-width: 0px; outline-color: initial !important;"></a></td><td width="72" style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><a style="box-sizing: border-box; background-color: transparent; color: rgb(0, 0, 0); text-decoration-line: underline; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-style: none; outline-width: 0px; outline-color: initial !important;"></a></td><td width="75" style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><a style="box-sizing: border-box; background-color: transparent; color: rgb(0, 0, 0); text-decoration-line: underline; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-style: none; outline-width: 0px; outline-color: initial !important;"></a></td><td width="77" style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><a style="box-sizing: border-box; background-color: transparent; color: rgb(0, 0, 0); text-decoration-line: underline; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-style: none; outline-width: 0px; outline-color: initial !important;"></a></td></tr></tbody></table></td><td style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><table cellspacing="0" cellpadding="0" width="72" border="0" style="border-spacing: 0px; border-collapse: collapse; background-color: transparent; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tbody style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"> </td><td style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"> </td><td style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"> </td></tr></tbody></table></td></tr></tbody></table></td></tr><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><table cellspacing="0" cellpadding="0" width="652" border="0" style="border-spacing: 0px; border-collapse: collapse; background-color: transparent; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tbody style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; text-align: justify; outline-style: none; letter-spacing: 0px; line-height: 22px;"><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"> <span style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"><span style="box-sizing: border-box; font-weight: 700; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><ins style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;">2015년 마지막 달인 12월, 국내 굴지의 대학병원 약사위원회 문턱을 넘어 선 행운의 약제들은 무엇일까.</ins></span></span></div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;">31일 메디파나뉴스가 서울대병원, 서울아산병원, 세브란스병원이 최근 공개한 12월 약사위원회 통과 의약품 목록을 분석해 봤다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><br></div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"><span style="box-sizing: border-box; font-weight: 700; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;">◆경쟁 의약품 나란히 통과 '눈길' =<span style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: middle;"> </span></span>차세대 인슐린 제제로 주목받고 있는 노보 노디스크의 '트레시바(성분명: 인슐린 데글루덱)'와 사노피의 '투제오(성분명: 인슐린 글라진)'는 동시에 서울대병원 DC를 통과했다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;">두 제품은 모두 기존 인슐린 제제의 '저혈당' 부작용을 개선한 제품으로 경쟁 품목으로 꼽히고 있다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;">급여화는 '트레시바'가 지난 5월 먼저 됐지만, 출시 시기는 '투제오'가 더 빠르다. '투제오'는 지난 11월 급여화가 함께 국내에 출시됐고 '트레시바'는 내년 1월 출시 예정인 것으로 알려졌다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"><span style="box-sizing: border-box; font-weight: 700; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;">◆'닥순요법' 서울아산 입성, 빅4병원 섭렵 =<span style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: middle;"> </span></span>인터페론 주사 없이 C형 간염을 치료하는 경구용 항바이러스 신약인 '다클린자-순베프라'가 서울아산병원을 끝으로 빅4병원에 안착했다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;">'다클린자-순베프라'는 삼성서울병원(7~8월), 서울대병원(8월), 세브란스병원(9월) 순으로 DC를 통과, 마지막으로 12월 서울아산병원에서도 처방코드를 획득했다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;">일명 '닥순요법'이라 불리는 '다클린자-순베프라'는 기존 치료제에 대한 대안을 필요로 하던 한국 C형간염 환자들의 의학적 요구를 충족시켜 줄 것으로 기대되고 있다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;">주사제인 인터페론과 리바비린을 1년 간 사용해야 하는 기존의 치료법과 달리 이 병용요법은 주사 치료가 필요없기 때문이다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"><span style="box-sizing: border-box; font-weight: 700; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;">◆'알콕시아', '젤잔즈', '자이데나'도 대형병원 입성 =</span><span style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: middle;"> </span>이밖에도 한국 MSD의 소염진통제 '알콕시아', 한국화이자제약의 류마티스관절염치료제 '젤잔즈', 동아에스티의 발기부전치료제 '자이데나' 등의 약제도 12월 대형병원 DC를 통과했다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"><ins style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><span style="box-sizing: border-box; font-weight: 700; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><span style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(58, 50, 195); outline-width: 0px; outline-style: none;"><ins style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;">서울아산병원 DC통과 의약품은</ins></span></span></ins><span style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: middle;"> </span>▲MSD 소염진통제 '알콕시아' ▲BMS C형간염 치료제 '다클린자' ▲지엘루비콘/<ins style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><span style="box-sizing: border-box; font-weight: 700; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><span style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(58, 50, 195); outline-width: 0px; outline-style: none;"><ins style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;">파마존 변비치료제 '유카본'</ins></span></span></ins><span style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(58, 50, 195); outline-width: 0px; outline-style: none;"><span style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: middle;"> </span></span>▲비씨월드제약 항원충제 '메로겔' ▲BMS C형간염 치료제 '순베프라' ▲SK케미칼 고셔병치료제 '브이프리브' 등이다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;">서울대병원 DC를 통과한 의약품은 ▲한림제약 정맥림프기능부전치료제 '엔테론' ▲노보노디스크제약 당뇨병치료제 '트레시바' ▲사노피 당뇨병치료제 '투제오' ▲CJ헬스케어의 불면증치료제 '사일레노' 등이다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;">세브란스병원 DC 통과 의약품은 ▲한국화이자 류마티스관절염치료제 '젤잔즈' ▲GSK HIV치료제 '트리멕' ▲한국애보트 설사치료제 '하이드라섹산' ▲부광약품 점안액 '아젭틴' ▲로슈 파킨슨병치료제 '마도파' ▲동아에스티 발기부전치료제 '자이데나'▲알보젠코리아 소염제 '메치론' ▲한국화이자 고혈압고지혈증복합제 '카듀엣' 등이다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;">전화: 02)571-1311<br style="box-sizing: border-box; border-width: 0px; border-style: initial; border-color: initial; vertical-align: top; outline-width: 0px; padding: 0px; outline-style: none; margin: 0px;">팩스: 02)571-1325<br style="box-sizing: border-box; border-width: 0px; border-style: initial; border-color: initial; vertical-align: top; outline-width: 0px; padding: 0px; outline-style: none; margin: 0px;"><a href="mailto:pharmazon@naver.com" style="box-sizing: border-box; background-color: transparent; color: rgb(0, 0, 0); margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-style: none; outline-width: 0px; outline-color: initial !important;">pharmazon@naver.com</a></div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"><br></div></div></div></td></tr></tbody></table></td></tr></tbody></table>
<table cellspacing="0" cellpadding="0" width="652" border="0" style="border-spacing: 0px; border-collapse: collapse; margin: 0px; padding: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; color: rgb(0, 0, 0); font-size: 12px; outline-width: 0px; outline-style: none;"><tbody style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><table cellspacing="0" cellpadding="0" width="652" border="0" style="border-spacing: 0px; border-collapse: collapse; background-color: transparent; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tbody style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td colspan="2" style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><div class="detailL" style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;">올해 마지막 대형병원에 입성한 약제들 살펴 보니…</div></td></tr><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td colspan="2" style="box-sizing: border-box; padding: 10px 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><a class="top_middle_title1" style="box-sizing: border-box; background-color: transparent; color: rgb(0, 0, 0); text-decoration-line: underline; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-style: none; outline-width: 0px; outline-color: initial !important;">서울대·서울아산·세브란스병원 12월 DC 결과 분석</a></td></tr><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td width="580" align="left" style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><table cellspacing="0" cellpadding="0" width="580" border="0" style="border-spacing: 0px; border-collapse: collapse; background-color: transparent; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tbody style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td width="200" align="left" style="box-sizing: border-box; padding: 10px 0px 5px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><a class="plan_1_1" style="box-sizing: border-box; background-color: transparent; color: rgb(0, 0, 0); text-decoration-line: underline; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-style: none; outline-width: 0px; outline-color: initial !important;">이효정기자 hyo87@medipana.com</a></td><td width="380" align="left" style="box-sizing: border-box; padding: 10px 0px 5px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><a class="plan_1_1" style="box-sizing: border-box; background-color: transparent; color: rgb(0, 0, 0); text-decoration-line: underline; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-style: none; outline-width: 0px; outline-color: initial !important;">2015-12-31 06:09</a></td></tr></tbody></table></td><td style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><table cellspacing="0" cellpadding="0" width="72" border="0" style="border-spacing: 0px; border-collapse: collapse; background-color: transparent; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tbody style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><a style="box-sizing: border-box; background-color: transparent; color: rgb(0, 0, 0); text-decoration-line: underline; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-style: none; outline-width: 0px; outline-color: initial !important;"></a></td><td style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><a href="http://medipana.com/news/news_list.asp?Page=&sWord=&MainKind=A&NewsKind=5&vCount=12&vKind=1" style="box-sizing: border-box; background-color: transparent; color: rgb(0, 0, 0); margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-style: none; outline-width: 0px; outline-color: initial !important;"></a> </td><td style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><a style="box-sizing: border-box; background-color: transparent; color: rgb(0, 0, 0); text-decoration-line: underline; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-style: none; outline-width: 0px; outline-color: initial !important;"></a></td></tr></tbody></table></td></tr><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td bgcolor="#afafaf" height="2" colspan="2" style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"></td></tr><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td height="10" colspan="2" style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"></td></tr><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td align="left" style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><table cellspacing="0" cellpadding="0" width="210" border="0" style="border-spacing: 0px; border-collapse: collapse; background-color: transparent; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tbody style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td width="63" style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><a style="box-sizing: border-box; background-color: transparent; color: rgb(0, 0, 0); text-decoration-line: underline; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-style: none; outline-width: 0px; outline-color: initial !important;"></a></td><td width="72" style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><a style="box-sizing: border-box; background-color: transparent; color: rgb(0, 0, 0); text-decoration-line: underline; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-style: none; outline-width: 0px; outline-color: initial !important;"></a></td><td width="75" style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><a style="box-sizing: border-box; background-color: transparent; color: rgb(0, 0, 0); text-decoration-line: underline; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-style: none; outline-width: 0px; outline-color: initial !important;"></a></td><td width="77" style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><a style="box-sizing: border-box; background-color: transparent; color: rgb(0, 0, 0); text-decoration-line: underline; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-style: none; outline-width: 0px; outline-color: initial !important;"></a></td></tr></tbody></table></td><td style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><table cellspacing="0" cellpadding="0" width="72" border="0" style="border-spacing: 0px; border-collapse: collapse; background-color: transparent; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tbody style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"> </td><td style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"> </td><td style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"> </td></tr></tbody></table></td></tr></tbody></table></td></tr><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><table cellspacing="0" cellpadding="0" width="652" border="0" style="border-spacing: 0px; border-collapse: collapse; background-color: transparent; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tbody style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><tr style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><td style="box-sizing: border-box; padding: 0px; margin: 0px; border: 0px; vertical-align: top; font-family: "Noto Sans KR", sans-serif; outline-width: 0px; outline-style: none;"><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; text-align: justify; outline-style: none; letter-spacing: 0px; line-height: 22px;"><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"> <span style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"><span style="box-sizing: border-box; font-weight: 700; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><ins style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;">2015년 마지막 달인 12월, 국내 굴지의 대학병원 약사위원회 문턱을 넘어 선 행운의 약제들은 무엇일까.</ins></span></span></div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;">31일 메디파나뉴스가 서울대병원, 서울아산병원, 세브란스병원이 최근 공개한 12월 약사위원회 통과 의약품 목록을 분석해 봤다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><br></div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"><span style="box-sizing: border-box; font-weight: 700; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;">◆경쟁 의약품 나란히 통과 '눈길' =<span style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: middle;"> </span></span>차세대 인슐린 제제로 주목받고 있는 노보 노디스크의 '트레시바(성분명: 인슐린 데글루덱)'와 사노피의 '투제오(성분명: 인슐린 글라진)'는 동시에 서울대병원 DC를 통과했다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;">두 제품은 모두 기존 인슐린 제제의 '저혈당' 부작용을 개선한 제품으로 경쟁 품목으로 꼽히고 있다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;">급여화는 '트레시바'가 지난 5월 먼저 됐지만, 출시 시기는 '투제오'가 더 빠르다. '투제오'는 지난 11월 급여화가 함께 국내에 출시됐고 '트레시바'는 내년 1월 출시 예정인 것으로 알려졌다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"><span style="box-sizing: border-box; font-weight: 700; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;">◆'닥순요법' 서울아산 입성, 빅4병원 섭렵 =<span style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: middle;"> </span></span>인터페론 주사 없이 C형 간염을 치료하는 경구용 항바이러스 신약인 '다클린자-순베프라'가 서울아산병원을 끝으로 빅4병원에 안착했다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;">'다클린자-순베프라'는 삼성서울병원(7~8월), 서울대병원(8월), 세브란스병원(9월) 순으로 DC를 통과, 마지막으로 12월 서울아산병원에서도 처방코드를 획득했다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;">일명 '닥순요법'이라 불리는 '다클린자-순베프라'는 기존 치료제에 대한 대안을 필요로 하던 한국 C형간염 환자들의 의학적 요구를 충족시켜 줄 것으로 기대되고 있다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;">주사제인 인터페론과 리바비린을 1년 간 사용해야 하는 기존의 치료법과 달리 이 병용요법은 주사 치료가 필요없기 때문이다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"><span style="box-sizing: border-box; font-weight: 700; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;">◆'알콕시아', '젤잔즈', '자이데나'도 대형병원 입성 =</span><span style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: middle;"> </span>이밖에도 한국 MSD의 소염진통제 '알콕시아', 한국화이자제약의 류마티스관절염치료제 '젤잔즈', 동아에스티의 발기부전치료제 '자이데나' 등의 약제도 12월 대형병원 DC를 통과했다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"><ins style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><span style="box-sizing: border-box; font-weight: 700; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><span style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(58, 50, 195); outline-width: 0px; outline-style: none;"><ins style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;">서울아산병원 DC통과 의약품은</ins></span></span></ins><span style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: middle;"> </span>▲MSD 소염진통제 '알콕시아' ▲BMS C형간염 치료제 '다클린자' ▲지엘루비콘/<ins style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><span style="box-sizing: border-box; font-weight: 700; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;"><span style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(58, 50, 195); outline-width: 0px; outline-style: none;"><ins style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-width: 0px; outline-style: none;">파마존 변비치료제 '유카본'</ins></span></span></ins><span style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(58, 50, 195); outline-width: 0px; outline-style: none;"><span style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: middle;"> </span></span>▲비씨월드제약 항원충제 '메로겔' ▲BMS C형간염 치료제 '순베프라' ▲SK케미칼 고셔병치료제 '브이프리브' 등이다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;">서울대병원 DC를 통과한 의약품은 ▲한림제약 정맥림프기능부전치료제 '엔테론' ▲노보노디스크제약 당뇨병치료제 '트레시바' ▲사노피 당뇨병치료제 '투제오' ▲CJ헬스케어의 불면증치료제 '사일레노' 등이다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;">세브란스병원 DC 통과 의약품은 ▲한국화이자 류마티스관절염치료제 '젤잔즈' ▲GSK HIV치료제 '트리멕' ▲한국애보트 설사치료제 '하이드라섹산' ▲부광약품 점안액 '아젭틴' ▲로슈 파킨슨병치료제 '마도파' ▲동아에스티 발기부전치료제 '자이데나'▲알보젠코리아 소염제 '메치론' ▲한국화이자 고혈압고지혈증복합제 '카듀엣' 등이다.</div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;">전화: 02)571-1311<br style="box-sizing: border-box; border-width: 0px; border-style: initial; border-color: initial; vertical-align: top; outline-width: 0px; padding: 0px; outline-style: none; margin: 0px;">팩스: 02)571-1325<br style="box-sizing: border-box; border-width: 0px; border-style: initial; border-color: initial; vertical-align: top; outline-width: 0px; padding: 0px; outline-style: none; margin: 0px;"><a href="mailto:pharmazon@naver.com" style="box-sizing: border-box; background-color: transparent; color: rgb(0, 0, 0); margin: 0px; padding: 0px; border: 0px; vertical-align: top; outline-style: none; outline-width: 0px; outline-color: initial !important;">pharmazon@naver.com</a></div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"> </div><div style="box-sizing: border-box; margin: 0px; padding: 0px; border: 0px; vertical-align: top; color: rgb(0, 0, 0); outline-width: 0px; outline-style: none;"><br></div></div></div></td></tr></tbody></table></td></tr></tbody></table>
